• Nightfood Holdings makes ice cream formulated by sleep and nutrition experts
• The company’s CEO will speak at the upcoming 13th Annual Global Dairy Congress
• Nightfood is filing for international trademark protection within the ice cream category

An innovative consumer goods brand-development company, Nightfood Holdings Inc. (OTCQB: NGTF) owns Nightfood Inc. and its wholly owned subsidiary, MJ Munchies Inc. Located in Tarrytown, New York, Nightfood is the creator of tasty, award-winning, better-for-you ice cream formulated by sleep and nutrition experts. The company has optimized the macro-nutrient and ingredient profiles of its sleep-friendly products for nighttime.

The company’s mission is to solve America’s $50 billion nighttime snacking problem. An estimated 85 percent of American adults aged 18-54 regularly snack at night, and the most popular choices tend to be high in fat, calories and sugar, contributing to impaired sleep. The company chooses sleep-friendly options regarding protein sources, fiber content, lactose content, amino acids, minerals, enzymes, all-natural sweeteners and more (http://ibn.fm/to5vr). The company’s products contain no sleep-aid substances or drugs.

Established in 2018, the MJ Munchies Inc. subsidiary is working to capitalize on legally compliant opportunities in cannabidiol (CBD), marijuana edibles and related markets. The company’s intention is to market a portion of the new products under the brand name ‘Half-Baked’, for which Munchies has successfully secured trademark rights (http://ibn.fm/F683w).

In a further indication of the company’s growing clout, Nightfood Inc. Chief Executive Officer Sean Folkson has been invited to speak at the 13th Annual Global Dairy Congress. The event will take place in Lisbon, Portugal, at the Myriad by Sana Hotel. The three-day conference is scheduled to begin on June 25 and run through June 27. Zenith Global, a UK-based food and drink consultancy, is coordinating the event (http://ibn.fm/sFPyb).

“It’s an honor to be invited as a guest speaker at such a prestigious global industry conference at this very early stage in our brand life-cycle,” Folkson said in a news release. “Zenith’s confidence that what we’re doing is worthy of such an audience reinforces our belief in our mission. I look forward to discussing the Nightfood brand platform and the concept of sleep-friendly nutrition, which we’re pioneering, with the leaders in the industry.”

Recently, Nightfood received notice from the U.S. Patent and Trademark Office that all requirements have been satisfied for registration of the Nightfood mark for ice cream in the United States (http://ibn.fm/bqGU7). The company anticipates formal registration will come in late spring. Moreover, the company started the process of registering the Nightfood mark for its ice cream brand in select strategic worldwide territories.

“While we’re not out there proactively seeking international opportunities at this time, we do feel overseas expansion is in our future assuming we’re able to properly execute here in the U.S. first,” Folkson added. He further noted that, while continuing talks with legitimate global trade partners are underway, no firm schedule for worldwide expansion is in place. Nightfood is filing for international trademark protection because of manifold inquiries received from overseas entities desiring to introduce Nightfood ice cream to local markets.

Nightfood Holdings continues to innovate with its sleep-friendly ice cream products, as additional flavors are currently in development, including non-dairy options. The company won the 2019 ‘Product of the Year’ award in a survey of more than 40,000 consumers (http://ibn.fm/bsQl7). For investors, Nightfood offers the potential for portfolio growth as it has now secured distribution in 15 states and continues to advance toward its stated goal of 10,000 points of distribution by March 31, 2020, with its award-winning product line.

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• Analysts project that the traditional nutraceutical health and wellness market for CBD products will reach $6.4 billion by 2025
• As ETST widens its sales efforts, analysts cite increases of CBD availability in diverse retail channels
• ETST has entered new distribution deals with CannaBiz and Desert Sun Distribution, providing more opportunities for its CBD products

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is marketing its full-spectrum CBD products to a broader retail audience, such as large chains, health food stores and independent pharmacies. This strategic move comes as five Cowen & Co. analysts project that CBD consumer products are winning diverse shelf space in locations that include online sites, specialty outlets such as Sephora and fine department stores, including Neiman Marcus (http://ibn.fm/8GxyT).

In Cowen’s ‘Collective View of CBD’, five analysts collectively project that CBD sales will reach $16 billion in the United States by 2025. Within that total, they estimate that the leading submarket consists of traditional health and wellness nutraceuticals at $6.4 billion. This projection bodes well for ETST as it works to widen its reach to chain retailers, independent pharmacies and others. One reason independent pharmacies like to sell CBD oils is because the product offers high margins and differentiation from larger competitors, such as Walgreen’s and CVS.

Through agreements with CannaBiz and Desert Sun Distribution, ETST plans to broaden its sales of CBD products, including full-spectrum cannabinoid oil, to large chains, health food stores, pharmacies, chiropractors, dispensaries, health care practitioners, athletic clubs and clinics throughout the country (http://ibn.fm/ymIfU), and this move is only the beginning for the biotech company. “The distribution agreements with CannaBiz and Desert Sun Distribution, while important, are only a fraction of the opportunities we see for our CBD products,” ETST Chief Sales Officer David Burbash stated in a news release.

In addition to the $16 billion estimate, the Cowen & Co. analysis projects that CBD products in the U.S. will reach 10 percent of U.S. adults. The report noted that, in a survey of 2,500 adults, approximately 6.9 percent of Americans already use CBD as a supplement (http://ibn.fm/PNrok). The survey also found that CBD use is most common among consumers aged 18-34. Tinctures (or liquid extracts) accounted for 44 percent of the market, followed by topicals at 26 percent, capsules at 22 percent and beverages at 19 percent (Note: figures total more than 100 percent).

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• The United Organic strain is now shipping to more than 200 medical patients enrolled as Growers’ Circle members in Canada
• TGOD’s second organic certification for its Hamilton facility was recently received from Pro-Cert Organic Systems Ltd.
• Company’s multi-year extraction services agreement with Valens GroWorks Corp. is expected to accelerate the market entry of CBD-infused products

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is focused on becoming the global leader in delivering premium organic cannabis solutions to enhance the lives of people around the world. If 2018’s accomplishments are any indication of what’s to come, then TGOD is well on its way to realizing its strategic vision, as TGOD Director and CEO Brian Athaide stated in a news release (http://ibn.fm/Pfc4u).

“2018 has been a pivotal year for the company. The accomplishments our team has made have been nothing shy of incredible,” Athaide noted in the release. “The company has raised substantial capital and grown the team with the addition of deep expertise and exceptionally skilled professionals to both management and our board. We are very excited for 2019 and we remain focused on delivering on the company’s operational plans of producing and bringing to market high quality, premium certified organic cannabis.”

Recent company highlights include recognition of its redesigned website, TGOD.ca, which received two prestigious Horizon Interactive Awards in the global categories of ‘Best Responsive / Mobile Website (Gold)’ and ‘Best E-commerce Website (Bronze)’. The awards indicate much more than a job well done, according to Athaide (http://ibn.fm/6e9ig).

“Having launched in only December 2018, the fact that we are already receiving awards is remarkable. This recognition showcases the importance of not only building a leading digital platform for the cannabis industry, but a platform that competes across all industries,” Athaide added.

The new website focuses on driving awareness of TGOD’s position as Canada’s only 100 percent supplier of certified organic cannabis while facilitating direct medical product purchases for patients that provide medical documentation that’s confirmed by a health care practitioner. In March, the first group of patients enrolled in TGOD’s Growers’ Circle received access to purchase the company’s first certified-organic cannabis strain through the website (http://ibn.fm/sv3S6). The Growers’ Circle launch is a limited production rollout of TGOD’s premium product, allowing the company to perfect its distribution ahead of its production ramp-up and scaled rollout this year. Early feedback has been extremely positive, the company reports.

TGOD cannabis is grown in living soil without synthetic fertilizers, pesticides or herbicides, and it is certified-organic by ECOCERT and Pro-cert, both of which are pre-eminent global certification bodies (http://ibn.fm/Oe6d2). Hill & Knowlton consumer research confirmed that 60 percent of medical cannabis patients prefer certified-organic product. TGOD flower is packaged in recyclable glass jars and speaks to the company’s product quality, sustainability and regenerative philosophy.

“These global recognitions provide validation that we have built a scalable best-in-class website that works for patients, organic enthusiasts and investors,” said Andrew Pollock, TGOD’s vice president of marketing.

Another highlight is the company’s recent entry into a multiyear extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF), a licensed provider of cannabis products and services specializing in various proprietary extraction, distillation, cannabinoid isolation and purification technologies. The agreement underscores the company’s focus on meeting a growing need to furnish high-quality, premium organic cannabis products to Canadian consumers, according to a news release (http://ibn.fm/C0jf6).

With a funded capacity of 219,000 kilograms, TGOD is uniquely positioned between the medical and recreational cannabis industries and offers a compelling opportunity for perceptive investors. TGOD is constructing 1.64 million square feet of facilities across Ontario, Quebec, Denmark and Jamaica and continues to develop strategic partnerships around the globe.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• Company recently launched wellness products and an affiliate opportunity in the UK
• Extraction test batches are expected to help determine the final sales terms for the company’s 2018 harvest
• MCOA is currently focused on the production of approximately 50,000 clones and the early stages of micropropagation techniques
• Company seeks to take advantage of every profit point, from seed to finished product

As an umbrella company, Marijuana Company of America Inc. (OTCQB: MCOA) provides turnkey services to the legal cannabis and industrial hemp industries by delivering recognized brands through unique marketing and distribution subsidiaries. In the last few months, the company has announced an affiliate program and updated investors on the progress of a joint venture focused on the extraction of its 2018 hemp crop. The company is also working toward cloning the 2019 hemp crop, with its eyes on additional scientific advances for an even higher yield in the future. Strategically, MCOA is focusing on creating green, sustainable hemp-based products and technologies that provide a lasting positive impact.

The company officially launched its hempSMART wellness products and affiliate opportunity in the United Kingdom during a March event in London. hempSMART’s wellness and personal care products are created from organically grown, hemp-based CBD and synergistic botanicals. The company’s launch opportunity included an in-depth overview of the CBD industry, as well as marketing and compensation plans for associates interested in beginning their own businesses. hempSMART is encouraging new global affiliates to join in the company’s vision of promoting physical, financial and planetary health.

On April 1, the company and its joint venture partner, Global Hemp Group, provided an update regarding the processing of the 2018 hemp harvest from the joint venture’s Scio farm, as well as the cloning process for the 2019 harvest and planned expansion (http://ibn.fm/3D0Zc).

The release notes that the Scio farm team has prepared processing samples from the 2018 harvest for several Oregon-based extraction companies. The samples range in size from 100 lbs. to 2,000 lbs. Results from the extraction test batches are expected within the next week or two. These results will help determine the final terms of the sale of the harvested hemp biomass. Local farmers have also expressed an interest in working with the joint venture to grow hemp in 2019. The company is evaluating this opportunity and others as it looks to expand operations in Oregon.

In addition, the farm team is working toward production of approximately 50,000 clones. These clones are expected to reduce and possibly eliminate the need to acquire additional seeds or clones. Once the needed number of clones are produced from the initial 400 “mother” plants, they will be relocated to the propagation greenhouse to root. When viable, the clones will be planted on the lower 35 acres of the Scio farm for the 2019 season. The planting is expected to take place in late May or early June.

MCOA has also begun preliminary exploration into the micropropagation of hemp plants. The company believes that micropropagation techniques can more efficiently provide plants with higher-yielding and more profitable CBD content than seeds or cloning.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• After successful launch of hempSMART in London, MCOA will follow up with additional launch events in Birmingham and Liverpool
• In London, hempSMART sold out its entire promotional inventory, and more than 1,000 people signed up with the company’s associate networking program
• MCOA and joint venture partner Global Hemp Group are in negotiations with cannabinoid extraction companies in Oregon

Marijuana Company of America Inc. (OTCQB: MCOA) is widening its hempSMART subsidiary’s penetration into Europe by planning Q2 2019 prelaunch events in the Netherlands and Germany. MCOA is following up on the successful launch of hempSMART in London, where all promotional inventory was sold and more than 1,000 people joined the company’s associate networking program (http://ibn.fm/YUup4).

MCOA’s subsidiary, hempSMART, will also add to its successful March brand launch in London with additional launch events in Birmingham and Liverpool. In a news release, MCOA CEO Donald Steinberg said, “HempSMART will continue to put in place the proper preparations to launch in additional EU countries moving forward.”

In addition, MCOA, together with partner Global Hemp Group (CSE: GHG) (OTC: GBHPF) (FRA: GHG), is negotiating with several cannabinoid extraction companies in Oregon for the acquisition of the joint venture’s hemp biomass produced at its Scio farm. Samples processed from the 2018 hemp biomass harvest are being prepared for the extraction companies. Hemp biomass is being processed into CBD crude oil, with results from the extraction test batches expected by mid-April (http://ibn.fm/O5Tpb).

The joint venture partners may also work with local farmers in 2019 to grow hemp in Oregon. This would create another potential joint venture opportunity for MCOA and Global Hemp Group.

MCOA conducts product research and development of legal hemp-based consumer products containing CBD under the brand name ‘hempSMART’. Focused on general health and well-being, MCOA also conducts an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• Black Iron Inc. is focusing on its Shymanivske iron ore project in Ukraine
• The company’s projects are in the heart of Ukraine’s iron ore belt
• Black Iron recently closed the final tranche of a private placement

Based in Toronto, Ontario, Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company. Its focus is on advancing to production its 100-percent-owned Shymanivske iron ore project in Krivyi Rih, Ukraine. This project is in a mining-friendly area surrounded by five other operating iron ore mines. Shymanivske is positioned 330 kilometers southeast of Kiev in central Ukraine, the heart of the KrivBass iron ore mining district (http://ibn.fm/wCgrR).

The Shymanivske iron ore project boasts premier infrastructure, including nearby power and rail, and five sea ports. In addition, the project features a skilled workforce from Krivyi Rih, a city with a population of 750,000 that’s located only eight kilometers from the project site (http://ibn.fm/Z6YyV).

The Shymanivske project is expected to produce an ultra-high-grade, 68 percent iron ore concentrate with nominal impurities, including alumina and phosphorus, at a low operating cost of $31 per tonne and capital intensity of less than $95 per tonne of capacity. Black Iron’s plan is to produce high-grade pellet feed. The company’s concentrate could be used to make sinter or highly valued pellets. The concentrate is an ideal source for pellets, because it doesn’t need to be ground finer.

High-grade pellet feed is set to disproportionately increase in price. The price premium is increasing because of environmental consciousness, mainly in China. Since November 2018, iron ore prices have risen by close to 40 percent. Currently, the price of iron ore has reached its highest levels in almost a year (http://ibn.fm/O5y5x).

In addition, a NI 43-101-compliant resource report and engineering studies have been completed for Shymanivske. The NI 43-101-compliant resource contains 646Mt measured & indicated resources at 31.6 percent iron and an additional 188Mt inferred resource at 30.1 percent iron that will be concentrated to approximately 68 percent iron. The resource is defined by roughly 54,000 meters of drilling. Additionally, there is the potential for resource expansion from more drilling at depth.

The Shymanivske iron ore project features strong economics and a favorable tax rate (http://ibn.fm/qaIaA). The project will involve a phased build beginning at 4MTpa and growing to 8MTpa. Using a $62/T selling price produces a pre-tax NPV (net present value) of $2.1 billion at an 8 percent discount rate and a 43 percent IRR (internal rate of return) ($1.7 billion and 36 percent after-tax).

Recently, Black Iron closed the second and final tranche of its earlier announced non-brokered private placement of units (http://ibn.fm/IcRko). The company intends to use the net proceeds of the offering to secure essential land surface rights and further discussions on construction financing, as well as for general working capital purposes.

Black Iron offers investors an intriguing investment opportunity. The company’s mining permit at Shymanivske encompasses 2.56 square kilometers and is valid until 2024. Moreover, the permit is renewable in 20-year increments. With construction at the Shymanivske iron ore mine set to begin in the coming year, Black Iron is on course for major growth.

The technical and scientific contents of this article have been reviewed and approved by Matt Simpson, P.Eng., CEO of Black Iron, who is a Qualified Person as defined by NI 43-101.

For more information, visit the company’s website at www.BlackIron.com

NOTE TO INVESTORS: The latest news and updates relating to BKIRF are available in the company’s newsroom at http://ibn.fm/BKIRF

• Cannabis Strategic Ventures supports entrepreneurial growth in the emerging legal cannabis and ancillary spaces
• The company boasts a portfolio of unique subsidiaries driving growth and opportunities for vertical integration
• The company is developing its NUGS Farm, and developing other hard asset projects is a priority for Cannabis Strategic Ventures

Cannabis Strategic Ventures Inc. (OTC: NUGS) incubates, develops and partners with category leaders within the cannabis space. Through a selective portfolio of companies, NUGS works to support entrepreneurial growth within the fast-emerging legal cannabis sector. Headquartered in Los Angeles, the company offers outsourced personnel solutions that are custom-made for its diverse clientele.

Cannabis Strategic focuses on leading the way in defining industry best practices for innovation, brand development and product quality. Additionally, the company is committed to implementing a strong foundation of operational infrastructure (http://ibn.fm/Fgad9). Cannabis Strategic is accomplishing these goals by way of its various subsidiaries, which include Asher House Wellness, BudHire, Fitamins, Halo Filters, LYXR and Pure Organix.

Asher House Wellness makes Asher House Wellness Oil, an ingestible oil containing a wide variety of premium hemp phytocannabinoids. For pet consumption, these phytocannabinoids originate from hemp plants grown in the United States. The Asher House’s founding team was recently featured on The Ellen DeGeneres Show.

The company’s BudHire subsidiary matches leading candidates to a wide array of cannabis industry jobs. Offering temporary, seasonal and permanent staffing solutions, BudHire also provides sector-specific professional employment organization and human resources consulting services (http://ibn.fm/jN6s6). Cannabis Strategic intends to leverage Worldwide Staffing’s know-how to expand its business operations into the cannabis staffing market.

The company’s Fitamins subsidiary manufactures sports performance products derived from phytocannabinoids, hyaluronic acid and MSM (methylsulfonylmethane). Cannabis Strategic’s Halo Filters subsidiary has developed industry-leading filters made of patent-pending materials. These materials lessen the presence of harmful chemicals and protect lungs.

The company’s LYXR subsidiary produces a line of luxury skin care products derived from hemp CBD (cannabidiol) and other ingredients. The focus of these products is hydration, regeneration and anti-aging. Moreover, the Pure Organix subsidiary concentrates on products that include PureOrganix. This is a line of high-quality cannabis oil concentrates that are organic and compliant with current Good Manufacturing Practices (cGMP) and Food and Drug Administration (FDA) guidelines.

Furthermore, Cannabis Strategic has an initiative to launch substantial cannabis cultivation with its 20 licenses and NUGS Farm, a six-acre cultivation site (http://ibn.fm/c7FzE). The company also plans to partner with a Santa Barbara County cultivation operation that holds approximately 40 commercial cannabis licenses in Southern California.

In a news release, Cannabis Strategic Ventures CEO Simon Yu said, “Establishing the NUGS Farm and securing these licenses are significant milestones for Cannabis Strategic Ventures. We are proud of what we have accomplished at this stage of the company.”

Cannabis Strategic is clearly spearheading innovation in the vibrant cannabis sector. The company is positioned to capitalize in a cannabis marketplace that’s seeing dynamic growth. Forbes recently noted that the legal cannabis industry should experience significant growth in North America and around the world (http://ibn.fm/Q5DMn). The publication predicted that the largest group of cannabis purchasers will be in North America and that spending will increase from $9.2 billion in 2017 to $47.3 billion by 2027.

Cannabis Strategic Ventures offers a compelling opportunity for clients and investors alike. The company has a vision to shape the cannabis industry’s future by focusing on continual advancement in products, places and people. With brands that are category leaders, Cannabis Strategic Ventures continues to foster exponential growth.

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• Hemp industry’s growth exhibiting boom trends in wake of the 2018 Farm Bill’s passage, altering regulatory oversight of the plant
• Sugarmade is focusing efforts on supporting the nascent hemp industry with hydroponic growth supplies
• The company has also signed a supply agreement with Kentucky-based private hemp cultivator Hempistry to support Hempistry’s micropropagation work
• Micropropagation helps growers ensure plant quality by cloning “mother” plants that exhibit preferred genetic traits

Hydroponic agriculture supplier Sugarmade Inc. (OTCQB: SGMD) is preparing to significantly expand its operations in the hemp cultivation industry following recent regulatory changes in the agriculture sector and a new agreement with Kentucky-based hemp cultivator Hempistry Inc. to deliver resources for its plant micropropagation work.

Hemp cultivation is beginning to flourish, after decades of federal prohibition in the United States ceased with President Donald Trump’s signing of the 2018 Farm Bill late last year. Limited research cultivation gave way to full-scale agricultural potential for raising hemp crops, creating anticipation for hydroponics specialty product suppliers such as Sugarmade that are functioning as supportive industries for the boom in grower interest.

Sugarmade’s supply contract with Hempistry for the latter’s micropropagation operations is expected to be an ongoing relationship, as Hempistry grows domestically and into the international arena.

Micropropagation is a process that involves cloning or “propagating” new hemp plants from existing “mother” plants that have shown a desirable genetic profile. Much of the hemp cultivated in North America is grown through this propagation process rather than from seed, and the micropropagation process not only ensures exact replicas of the best mother plants but also allows for a very large number of plants to be readied simultaneously, according to the company.

“With at least 42,000 acres of hemp expected to be planted in Kentucky and considering an average plant density per acre of well over 1,000, farmers in Kentucky will need hundreds of millions of clones over the coming years,” Sugarmade CEO Jimmy Chan, who is also a Hempistry director, stated in a news release. “When these numbers are multiplied over the many other hemp cultivation states, it is easy for anyone to see the strong demand scenario that is quickly developing.”

Kentucky found itself in a position of eminence amid the long-running debate over the Farm Bill’s passage, which was championed by Senate Majority Leader Mitch McConnell, the senior congressman from the Bluegrass State. McConnell pushed for the bill’s passage in large measure to ensure that hemp could be legally grown as an agricultural product without Drug Enforcement Administration prohibition (http://ibn.fm/OrSSG) in an effort to revive the state’s flagging flagship industry. The bill’s success and successive agricultural efforts in Kentucky have led the media to begin branding (http://ibn.fm/cEUm7) the state as the ‘Silicon Valley of Hemp’.

Kentucky farming officials have begun to pin their hopes on hemp as an up-and-coming successor to the state’s tobacco industry, which has a long-controversial history because of tobacco’s impact on users’ health.

“We don’t know if industrial hemp will replace tobacco, but we are going to champion it,” Kentucky Commissioner of Agriculture Ryan Quarles told news outlet CNBC (http://ibn.fm/Kz9i4).

According to the commissioner, the number of the state’s applications for hemp cultivation this year is expected to increase about five times from 2018. Hemp growth is on track to top 50,000 acres this year, up from 16,000 acres for last year, according to the report. With the boom in hemp cultivation occurring this planting season, many of the supplies required for successful micropropagation operations are in very short supply, which makes the Hempistry agreement particularly valuable to both companies.

Sugarmade acquired an option last year to invest up to $1 million in the Hempistry operation at a locked-in 2018 valuation. Privately-held Hempistry expects to engage in both direct cultivation and co-op cultivation activities with local farmers this year. Chan noted that Sugarmade has already commenced processing of micropropagation supply orders.

CNBC’s report notes that Hemp Business Journal expects the hemp industry to reach $1.9 billion in revenues by 2022, up 90 percent from about $1 billion in 2018, while a bullish estimate by researcher Brightfield Group forecasts that the hemp-derived CBD-infused product market could reach $22 billion during the same time period.

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• SinglePoint recorded a 344 percent increase in sales during 2018, largely due to the acquisition of its DIGS and JAG subsidiaries in 2017
• The revenue growth amounted to a nearly 10-fold increase in profits, to $267,799
• SinglePoint’s most recent asset purchase agreement, solar energy industry marketers Direct Solar and its affiliate, AI Live Transfers, is expected to begin generating revenues for the company this month

Diversified technology company SinglePoint Inc. (OTCQB: SING) has filed its first annual statement with the Securities and Exchange Commission as a fully reporting issuer, highlighting the successes of the company’s merger and acquisition strategy during 2018, as well as its outlook for the coming months.

The report shows that sales increased by 344 percent during the year, leading to a total of more than $1.1 million by year’s end (http://ibn.fm/AGCYj) as the company solidified its financial position.

The company became a fully reporting entity in August 2018.

“Beginning in fiscal year 2014, we made a strategic decision to transition from a technology-based solutions provider to an acquisition and funding development partner… with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration,” SinglePoint stated in the 10-K report. “The Company is looking to tap into markets with exponential growth opportunities such as blockchain, cannabis, sports betting and mobile payments… Our gross profit was $267,799, for the year ended December 31, 2018, compared with $27,814, for the year ended December 31, 2017.” The nearly 10-fold increase in profits was attributable to SinglePoint’s acquisitions in 2017, primarily the company’s DIGS and JAG subsidiaries.

SinglePoint recently announced that it is pinning new revenue hopes on an agreement to acquire Direct Solar and AI Live Transfers — two companies utilizing the Lending Tree model to market products and services to solar power consumers by providing technological resources that consumers can use to comparatively shop for the solar providers that are best suited to their needs (http://ibn.fm/xVeK4). SinglePoint expects to begin realizing profits from the Direct Solar acquisition this month.

Direct Solar’s revenues have recorded an exponential gain during the past year, topping $1.5 million, and a company press release about the agreement states that the companies expect revenues to exceed $8.2 million during the coming year, reaching about $14 million during the year after that, with annual profits of more than $2.8 million forecast after two years.

“We have spent a lot of time and effort to put the Company in a position to turn a profit in the very near future. With the anticipated acquisition of Direct Solar and the explosive growth we are seeing that goal could become a reality. We are excited about the future of SinglePoint and are in a stronger position now than we have ever been,” CEO Greg Lambrecht stated in a news release.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• Lexaria Bioscience is focusing on its pioneering DehydraTECH drug delivery technology
• The company boasts a portfolio of unique products
• Lexaria continues to conduct research regarding DehydraTECH technology for oral nicotine

Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Lexaria is the only global company with patents issued for the oral delivery of all cannabinoids. The company has developed and out-licenses its innovative and cost-effective DehydraTECH drug delivery platform. This technology changes the way that edible cannabinoids enter the body. DehydraTECH delivery technology offers a viable and often healthier substitute to other delivery processes for bioactive substances (http://ibn.fm/yih3f).

Lexaria Biosciences’ proprietary technology improves the taste, speed and delivery of bioactive compounds, including nicotine and cannabinoids. DehydraTECH is proven effective in multiple worldwide studies in significantly assisting the quantity of absorption of a range of lipophilic (fat-soluble) bioactive molecules. DehydraTECH also eliminates the strong tastes and odors of lipophilic compounds. Notably, this technology does so without the need for added sugar or sweeteners (http://ibn.fm/BPOdn).

Furthermore, the DehydraTECH drug delivery platform increases bio-absorption by up to 10 times and lessens the time of onset, with effects being felt within 15 to 20 minutes, as compared to 60 to 120 minutes without the platform. In addition, the technology is patent protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids. Patents are also granted for THC (tetrahydrocannabinol), other psychoactive compounds and NSAIDs (nonsteroidal, anti-inflammatory drugs), as well as nicotine and other molecules.

Lexaria Bioscience has partnered with one of the world’s largest tobacco companies to fund the research and development of the DehydraTECH technology for oral nicotine. Through wholly owned subsidiary Lexaria Nicotine LLC, Lexaria is working to propel innovation in oral, reduced-risk nicotine consumer products utilizing DehydraTECH (http://ibn.fm/1JjdR).

Lexaria’s goal is to perform an extensive series of clinical investigations of oral types of nicotine delivery, funded by its partner, using DehydraTECH technology. The DehydraTECH platform has been shown to deliver nicotine to the brain quicker than traditional delivery systems. The technology could potentially apply to the treatment of nervous system diseases, including Alzheimer’s disease. Moreover, DehydraTECH avoids the dangers associated with smoking.

Lexaria also offers a suite of diverse products (http://ibn.fm/Mnu7n). These products include protein energy bars featuring fiber and protein; ViPova exotic teas, delivering cannabidiol in numerous flavors; and coffee. The company also sells TurboCBD capsules. These are high-absorption, full-spectrum hemp oil capsules. The capsules are designed to boost focus and memory while at the same time lessening fatigue and stress. TurboCBD capsules also contain ginseng and gingko.

Lexaria Bioscience is developing a patent family with supporting intellectual property (IP) in the pharmaceutical sector. Lexaria Pharmaceutical Corp. is the company’s wholly owned subsidiary. Lexaria Pharmaceutical has acquired exclusive international rights to Lexaria’s patent portfolio regarding pharmaceutical applications (http://ibn.fm/QNwSp).

Additionally, Lexaria Hemp Co. holds exclusive international rights to the Lexaria Bioscience patent portfolio regarding hemp-based applications. The Lexaria group also includes Lexaria CanPharm Corp., a Canadian entity. Lexaria CanPharm owns exclusive international rights to Lexaria’s IP applicable to psychotropic bioactive molecules, which act upon human CB1 and CB2 receptors in permitted areas.

Lexaria Bioscience is innovating on multiple fronts. The company’s business model offers the potential for considerable ROI, as it involves developing and out-licensing its DehydraTECH platform to third-party partners and distributors for enhanced revenue. Lexaria continues to move forward with its DehydraTECH drug delivery platform and the sale of company-developed and joint venture products.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP